ic 261 and Disease Exacerbation

ic 261 has been researched along with Disease Exacerbation in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Fang, T; Guo, M; Huang, P; Li, D; Qi, F; Rao, Q; Sun, J; Xia, J; Yang, B; Yuan, F; Zhao, Z	1

Other Studies

1 other study(ies) available for ic 261 and Disease Exacerbation

Article	Year
IC261 suppresses progression of hepatocellular carcinoma in a casein kinase 1 δ/ε independent manner. Biochemical and biophysical research communications, 2020, 03-12, Volume: 523, Issue:3 Topics: Animals; Carcinoma, Hepatocellular; Casein Kinase 1 epsilon; Casein Kinase Idelta; Cell Line, Tumor; Cell Proliferation; Disease Progression; Humans; Indoles; Liver Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Phloroglucinol; Protein Kinase Inhibitors	2020

Article

Year

IC261 suppresses progression of hepatocellular carcinoma in a casein kinase 1 δ/ε independent manner.

Biochemical and biophysical research communications, 2020, 03-12, Volume: 523, Issue:3

Topics: Animals; Carcinoma, Hepatocellular; Casein Kinase 1 epsilon; Casein Kinase Idelta; Cell Line, Tumor; Cell Proliferation; Disease Progression; Humans; Indoles; Liver Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Phloroglucinol; Protein Kinase Inhibitors

2020